Chris Smith
Chief Executive Officer chez NEOGENOMICS, INC.
Fortune : 11 M $ au 31/03/2024
Profil
Christopher Michael Smith est un homme d'affaires qui a été à la tête de 7 entreprises différentes. Il occupe le poste de président d'Agilitas USA, Inc, de président et de directeur général d'Ortho-Clinical Diagnostics, Inc, de président et de directeur général d'Ortho Clinical Diagnostics Holdings Plc et de directeur général d'Ortho-Clinical Diagnostics Italy Srl. Il est également membre du conseil d'administration de Neuromod Devices Ltd. et d'Akouos, Inc. Christopher Michael Smith a précédemment occupé les postes de directeur général et de directeur exécutif chez Cochlear Ltd. et de président de Cochlear Americas (une filiale de Cochlear Ltd.), de président et de directeur général de Gyrus Medical Ltd, de directeur financier et de vice-président par intérim chez ev3, Inc. et de président de groupe chez Gyrus Group Ltd. et de directeur chez Gray Cary Ware & Freidenrich LLP. M. Smith a obtenu un diplôme de premier cycle de l'université A&M du Texas.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NEOGENOMICS, INC.
0,47% | 25/03/2024 | 602 219 ( 0,47% ) | 9 M $ | 31/03/2024 |
QUIDELORTHO CORPORATION
0,05% | 06/06/2023 | 35 577 ( 0,05% ) | 2 M $ | 31/03/2024 |
Postes actifs de Chris Smith
| Sociétés | Poste | Début |
|---|---|---|
| NEOGENOMICS, INC. | Chief Executive Officer | 15/08/2022 |
Osler Diagnostics Ltd.
 Osler Diagnostics Ltd. BiotechnologyHealth Technology Osler Diagnostics Ltd. engages in research and development in biotechnology. The company was founded by Jason Davis and Paulo R. Bueno and is headquartered in Oxford, the United Kingdom. | Chairman | 21/03/2022 |
Ortho-Clinical Diagnostics Italy Srl
 Ortho-Clinical Diagnostics Italy Srl Medical SpecialtiesHealth Technology Ortho-Clinical Diagnostics Italy Srl manufactures and designs diagnostic, transfusion, and clinical equipment and systems. The firm provides total solutions for screening, diagnosing, monitoring and confirming diseases early before they put lives at risk. The company is headquartered in Milan, Italy. | Chief Executive Officer | - |
Agilitas USA, Inc.
 Agilitas USA, Inc. Medical/Nursing ServicesHealth Services Agilitas USA, Inc. engages in the provision of physical therapy services. The treatments it offers include dry needling therapy, manual therapy, and pelvic health speciality clinics. The company was founded by Garry Cunningham, Gregory Spurgin, and Tracy Caulkins in 1996 and is headquartered in Franklin, TN. | Chairman | 01/01/2018 |
Neuromod Devices Ltd.
 Neuromod Devices Ltd. Medical SpecialtiesHealth Technology Neuromod Devices Ltd. operates as a medical device company which engages in the research and development of neuromodulation technologies for chronic tinnitus. The firm develops proprietary neuromodulation technologies designed to address pathologies, which are believed to give rise to illusory perceptions, such as tinnitus. These technologies utilize bi-modal neuromodulation and aim to promote positive therapeutic change within the human nervous system. The company was founded by Ross O?Neill in 2010 and is headquartered in Dublin, Ireland. | Director/Board Member | 03/01/2019 |
Anciens postes connus de Chris Smith
| Sociétés | Poste | Fin |
|---|---|---|
| QUIDELORTHO CORPORATION | Director/Board Member | 31/08/2023 |
| AKOUOS | Director/Board Member | 15/08/2022 |
| ORTHO CLINICAL DIAGNOSTICS HOLDINGS PLC | Chief Executive Officer | 27/05/2022 |
Ortho-Clinical Diagnostics, Inc.
 Ortho-Clinical Diagnostics, Inc. Medical SpecialtiesHealth Technology Ortho-Clinical Diagnostics, Inc. engages in the manufacture and design of diagnostic, transfusion, clinical equipment, and systems. It provides solutions for screening, diagnosing, monitoring, and confirming diseases early before they put lives at risk. Its products include instrument systems and reagents that screen for AIDS and hepatitis C, as well as blood typing systems. The company was founded in 1939 and is headquartered in Raritan, NJ. | Chief Executive Officer | 27/05/2022 |
| ░░░░░░░░ ░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Chris Smith
| Texas A&M University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| NEOGENOMICS, INC. | Health Services |
| UNIVERSAL BIOSENSORS, INC. | Health Technology |
| COCHLEAR LIMITED | Health Technology |
| NYXOAH SA | Health Technology |
| QUIDELORTHO CORPORATION | Health Technology |
| Entreprise privées | 15 |
|---|---|
Startek, Inc.
 Startek, Inc. Miscellaneous Commercial ServicesCommercial Services Startek, Inc. engages in the provision of global customer experience solutions. Its solutions help global companies to connect emotionally with their customers, solve issues, and improve net promoter scores and other customer-facing performance metrics. The company offers multiple services, including sales, order management and provisioning, customer care, technical support, receivables management, and retention programs. It also manages programs using a variety of multi-channel customer interactions, including voice, chat, email, social media and back-office support. It operates through the following geographical segments: Americas, Malaysia, India and Sri Lanka, Australia, South Africa, and Rest of World. The company was founded by A. Emmet Stephenson and Michael W. Morgan in 1987 and is headquartered in Denver, CO. | Commercial Services |
ev3, Inc.
 ev3, Inc. Medical SpecialtiesHealth Technology ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support. | Health Technology |
Xtent, Inc.
 Xtent, Inc. Medical SpecialtiesHealth Technology Xtent, Inc. is a medical devices manufacturing company. The company develops drug-eluting stent systems for the treatment of multi-vessel, multi-lesion coronary and peripheral vascular diseases. Xtent was founded in 2002 and is headquartered in Menlo Park, CA. | Health Technology |
Acclarent, Inc.
 Acclarent, Inc. Medical SpecialtiesHealth Technology Acclarent, Inc. engages in manufacturing, designing, and commercializing medical devices that address conditions affecting the ear, nose, and throat. Its products include balloon sinuplasty, eustachian tube dilation, airway dilation system, and ethmoid punch. The company was founded by Joshua Makower and John Y. Chang in June 2004 and is headquartered in Irvine, CA. | Health Technology |
Gyrus Group Ltd.
 Gyrus Group Ltd. Medical SpecialtiesHealth Technology Gyrus Group Ltd. designs, develops, manufactures and markets electro-surgical systems. It operates in four segments: surgical, urology, gynaecology, ent, and partnered technologies. The firm supplies medical devices which reduce trauma and complications in surgery and develops tissue management systems, instruments and services. Gyrus Group was founded in 1989 and is headquartered in London, the United Kingdom. | Health Technology |
Ortho-Clinical Diagnostics, Inc.
Ortho-Clinical Diagnostics, Inc. Medical SpecialtiesHealth Technology Ortho-Clinical Diagnostics, Inc. engages in the manufacture and design of diagnostic, transfusion, clinical equipment, and systems. It provides solutions for screening, diagnosing, monitoring, and confirming diseases early before they put lives at risk. Its products include instrument systems and reagents that screen for AIDS and hepatitis C, as well as blood typing systems. The company was founded in 1939 and is headquartered in Raritan, NJ. | Health Technology |
Gyrus Medical Ltd.
 Gyrus Medical Ltd. Medical SpecialtiesHealth Technology Gyrus Medical Ltd. manufactures medical devices. It makes instruments used in minimally invasive surgical procedures which primarily focus on products used by general surgeons. The company is located in Cardiff, UK. | Health Technology |
| Gray Cary Ware & Freidenrich LLP | Commercial Services |
| Cochlear Americas | |
Ortho-Clinical Diagnostics Italy Srl
Ortho-Clinical Diagnostics Italy Srl Medical SpecialtiesHealth Technology Ortho-Clinical Diagnostics Italy Srl manufactures and designs diagnostic, transfusion, and clinical equipment and systems. The firm provides total solutions for screening, diagnosing, monitoring and confirming diseases early before they put lives at risk. The company is headquartered in Milan, Italy. | Health Technology |
Agilitas USA, Inc.
Agilitas USA, Inc. Medical/Nursing ServicesHealth Services Agilitas USA, Inc. engages in the provision of physical therapy services. The treatments it offers include dry needling therapy, manual therapy, and pelvic health speciality clinics. The company was founded by Garry Cunningham, Gregory Spurgin, and Tracy Caulkins in 1996 and is headquartered in Franklin, TN. | Health Services |
Neuromod Devices Ltd.
Neuromod Devices Ltd. Medical SpecialtiesHealth Technology Neuromod Devices Ltd. operates as a medical device company which engages in the research and development of neuromodulation technologies for chronic tinnitus. The firm develops proprietary neuromodulation technologies designed to address pathologies, which are believed to give rise to illusory perceptions, such as tinnitus. These technologies utilize bi-modal neuromodulation and aim to promote positive therapeutic change within the human nervous system. The company was founded by Ross O?Neill in 2010 and is headquartered in Dublin, Ireland. | Health Technology |
Akouos, Inc.
 Akouos, Inc. BiotechnologyHealth Technology Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA. | Health Technology |
Osler Diagnostics Ltd.
Osler Diagnostics Ltd. BiotechnologyHealth Technology Osler Diagnostics Ltd. engages in research and development in biotechnology. The company was founded by Jason Davis and Paulo R. Bueno and is headquartered in Oxford, the United Kingdom. | Health Technology |
Ortho Clinical Diagnostics Holdings Ltd.
 Ortho Clinical Diagnostics Holdings Ltd. Medical SpecialtiesHealth Technology Ortho Clinical Diagnostics Holdings Plc provides vitro diagnostics services. It offers VITROS XT 7600 Integrated System, VITROS 5600 Integrated System, VITROS 4600 Chemistry System, VITROS® XT 3400 Chemistry System, VITROS® 3600 Immunodiagnostic System, VITROS ECiQ Immunodiagnostic System, VITROS Automation Solutions, Informatics Solutions, Assay Menu by Disease State, Microtip Partnership Assays, VITROS HIV Combo Test, Transfusion Medicine, ORTHO VISION Analyzer, ORTHO VISION Max Analyzer, ORTHO CONNECT, ORTHO Workstation, Lab Reliability, Lab Optimization, Training & Education and Lab Support. The company was founded in 1997 and is headquartered in Raritan, NJ. | Health Technology |
